Loading clinical trials...
Loading clinical trials...
A Single-Center, Cross-over, Pilot Study Evaluating Acuvue® Oasys® Lenses (Senofilcon A), 30-Day Bausch + Lomb PureVision (Balafilcon A), and Clariti® 1-Day (Somofilcon A) Lenses, for Their Impact on Ocular Discomfort Induced by Exposure to the Turbo Controlled Adverse Environment™
Conditions
Interventions
Acuvue® Oasys® Lenses (senofilcon A)
30-Day Bausch + Lomb PureVision (balafilcon A)
+1 more
Locations
1
United States
Andover Eye Associates
Andover, Massachusetts, United States
Start Date
August 1, 2014
Primary Completion Date
September 1, 2014
Completion Date
September 1, 2014
Last Updated
April 25, 2024
NCT06650306
NCT06266728
NCT06052046
NCT05290727
NCT05036954
NCT04806763
Lead Sponsor
ORA, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions